Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection
Introduction The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temp...
Gespeichert in:
Veröffentlicht in: | Journal of neuro-oncology 2021-04, Vol.152 (2), p.339-346 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 346 |
---|---|
container_issue | 2 |
container_start_page | 339 |
container_title | Journal of neuro-oncology |
container_volume | 152 |
creator | Borger, Valeri Hamed, Motaz Ilic, Inja Potthoff, Anna-Laura Racz, Attila Schäfer, Niklas Güresir, Erdem Surges, Rainer Herrlinger, Ulrich Vatter, Hartmut Schneider, Matthias Schuss, Patrick |
description | Introduction
The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures.
Methods
Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6).
Results
Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9).
Conclusions
ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma. |
doi_str_mv | 10.1007/s11060-021-03705-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7997820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2487427740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</originalsourceid><addsrcrecordid>eNp9Uc1u1DAQthCILi0vwAFZ4tKLYZyx1wkHpKqCFqkSB1qpN8txnMVVEi92suryCDw1TlMK9MDBsjXfj2fmI-QVh7ccQL1LnMMaGBScASqQ7PYJWXGpkClU-JSsgK8Vk5W4PiAvUroBAKGQPycHiFKKosIV-fnV-R9TdDRMow29o36go-u3IZqObjof6s6kMfSGpiluXNy_p12onc2lPTWJzvVtNGMYMz-6lBEfhvza-H4xzfrkErVh2LlhBmfjGFJij0RH5FlruuRe3t-H5OrTx8vTc3bx5ezz6ckFs0KJkbXrpl632EBpGwMtRwRueWnAli26fKxEVYmqkVgj53ULlS2dRCglCFMAHpIPi-92qnvX2NxVHlZvo-9N3OtgvP4XGfw3vQk7rapKlXcGx_cGMXyfXBp175N1XWcGF6akC1EqUSglZuqbR9SbMMW8gsySIKUqSphZxcKy816iax-a4aDnqPUStc5R67uo9W0Wvf57jAfJ72wzARdCytCQs_vz939sfwEnG7nG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2505572800</pqid></control><display><type>article</type><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</creator><creatorcontrib>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</creatorcontrib><description>Introduction
The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures.
Methods
Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6).
Results
Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9).
Conclusions
ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</description><identifier>ISSN: 0167-594X</identifier><identifier>EISSN: 1573-7373</identifier><identifier>DOI: 10.1007/s11060-021-03705-x</identifier><identifier>PMID: 33554293</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Aged ; Anterior Temporal Lobectomy - methods ; Brain cancer ; Brain Neoplasms - complications ; Brain Neoplasms - surgery ; Clinical Study ; Convulsions & seizures ; Disease control ; Epilepsy ; Female ; Glioblastoma ; Glioblastoma - complications ; Glioblastoma - surgery ; Humans ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Neurology ; Oncology ; Seizures ; Seizures - etiology ; Seizures - surgery ; Surgery ; Treatment Outcome</subject><ispartof>Journal of neuro-oncology, 2021-04, Vol.152 (2), p.339-346</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</citedby><cites>FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</cites><orcidid>0000-0002-5905-4121</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11060-021-03705-x$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11060-021-03705-x$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33554293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borger, Valeri</creatorcontrib><creatorcontrib>Hamed, Motaz</creatorcontrib><creatorcontrib>Ilic, Inja</creatorcontrib><creatorcontrib>Potthoff, Anna-Laura</creatorcontrib><creatorcontrib>Racz, Attila</creatorcontrib><creatorcontrib>Schäfer, Niklas</creatorcontrib><creatorcontrib>Güresir, Erdem</creatorcontrib><creatorcontrib>Surges, Rainer</creatorcontrib><creatorcontrib>Herrlinger, Ulrich</creatorcontrib><creatorcontrib>Vatter, Hartmut</creatorcontrib><creatorcontrib>Schneider, Matthias</creatorcontrib><creatorcontrib>Schuss, Patrick</creatorcontrib><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><title>Journal of neuro-oncology</title><addtitle>J Neurooncol</addtitle><addtitle>J Neurooncol</addtitle><description>Introduction
The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures.
Methods
Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6).
Results
Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9).
Conclusions
ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</description><subject>Adult</subject><subject>Aged</subject><subject>Anterior Temporal Lobectomy - methods</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - complications</subject><subject>Brain Neoplasms - surgery</subject><subject>Clinical Study</subject><subject>Convulsions & seizures</subject><subject>Disease control</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Glioblastoma</subject><subject>Glioblastoma - complications</subject><subject>Glioblastoma - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Oncology</subject><subject>Seizures</subject><subject>Seizures - etiology</subject><subject>Seizures - surgery</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><issn>0167-594X</issn><issn>1573-7373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9Uc1u1DAQthCILi0vwAFZ4tKLYZyx1wkHpKqCFqkSB1qpN8txnMVVEi92suryCDw1TlMK9MDBsjXfj2fmI-QVh7ccQL1LnMMaGBScASqQ7PYJWXGpkClU-JSsgK8Vk5W4PiAvUroBAKGQPycHiFKKosIV-fnV-R9TdDRMow29o36go-u3IZqObjof6s6kMfSGpiluXNy_p12onc2lPTWJzvVtNGMYMz-6lBEfhvza-H4xzfrkErVh2LlhBmfjGFJij0RH5FlruuRe3t-H5OrTx8vTc3bx5ezz6ckFs0KJkbXrpl632EBpGwMtRwRueWnAli26fKxEVYmqkVgj53ULlS2dRCglCFMAHpIPi-92qnvX2NxVHlZvo-9N3OtgvP4XGfw3vQk7rapKlXcGx_cGMXyfXBp175N1XWcGF6akC1EqUSglZuqbR9SbMMW8gsySIKUqSphZxcKy816iax-a4aDnqPUStc5R67uo9W0Wvf57jAfJ72wzARdCytCQs_vz939sfwEnG7nG</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Borger, Valeri</creator><creator>Hamed, Motaz</creator><creator>Ilic, Inja</creator><creator>Potthoff, Anna-Laura</creator><creator>Racz, Attila</creator><creator>Schäfer, Niklas</creator><creator>Güresir, Erdem</creator><creator>Surges, Rainer</creator><creator>Herrlinger, Ulrich</creator><creator>Vatter, Hartmut</creator><creator>Schneider, Matthias</creator><creator>Schuss, Patrick</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5905-4121</orcidid></search><sort><creationdate>20210401</creationdate><title>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</title><author>Borger, Valeri ; Hamed, Motaz ; Ilic, Inja ; Potthoff, Anna-Laura ; Racz, Attila ; Schäfer, Niklas ; Güresir, Erdem ; Surges, Rainer ; Herrlinger, Ulrich ; Vatter, Hartmut ; Schneider, Matthias ; Schuss, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-f6db6f3d08cda0f13301c18a0c8f3e8f3c537949d53b311bf09c8e5308504a203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anterior Temporal Lobectomy - methods</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - complications</topic><topic>Brain Neoplasms - surgery</topic><topic>Clinical Study</topic><topic>Convulsions & seizures</topic><topic>Disease control</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Glioblastoma</topic><topic>Glioblastoma - complications</topic><topic>Glioblastoma - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Oncology</topic><topic>Seizures</topic><topic>Seizures - etiology</topic><topic>Seizures - surgery</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borger, Valeri</creatorcontrib><creatorcontrib>Hamed, Motaz</creatorcontrib><creatorcontrib>Ilic, Inja</creatorcontrib><creatorcontrib>Potthoff, Anna-Laura</creatorcontrib><creatorcontrib>Racz, Attila</creatorcontrib><creatorcontrib>Schäfer, Niklas</creatorcontrib><creatorcontrib>Güresir, Erdem</creatorcontrib><creatorcontrib>Surges, Rainer</creatorcontrib><creatorcontrib>Herrlinger, Ulrich</creatorcontrib><creatorcontrib>Vatter, Hartmut</creatorcontrib><creatorcontrib>Schneider, Matthias</creatorcontrib><creatorcontrib>Schuss, Patrick</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuro-oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borger, Valeri</au><au>Hamed, Motaz</au><au>Ilic, Inja</au><au>Potthoff, Anna-Laura</au><au>Racz, Attila</au><au>Schäfer, Niklas</au><au>Güresir, Erdem</au><au>Surges, Rainer</au><au>Herrlinger, Ulrich</au><au>Vatter, Hartmut</au><au>Schneider, Matthias</au><au>Schuss, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection</atitle><jtitle>Journal of neuro-oncology</jtitle><stitle>J Neurooncol</stitle><addtitle>J Neurooncol</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>152</volume><issue>2</issue><spage>339</spage><epage>346</epage><pages>339-346</pages><issn>0167-594X</issn><eissn>1573-7373</eissn><abstract>Introduction
The postoperative seizure freedom represents an important secondary outcome measure in glioblastoma surgery. Recently, supra-total glioblastoma resection in terms of anterior temporal lobectomy (ATL) has gained growing attention with regard to superior long-term disease control for temporal-located glioblastoma compared to conventional gross-total resections (GTR). However, the impact of ATL on seizure outcome in these patients is unknown. We therefore analyzed ATL and GTR as differing extents of resection in regard of postoperative seizure control in patients with temporal glioblastoma and preoperative symptomatic seizures.
Methods
Between 2012 and 2018, 33 patients with preoperative seizures underwent GTR or ATL for temporal glioblastoma at the authors’ institution. Seizure outcome was assessed postoperatively and 6 months after tumor resection according to the International League Against Epilepsy (ILAE) classification and stratified into favorable (ILAE class 1) versus unfavorable (ILAE class 2–6).
Results
Overall, 23 out of 33 patients (70%) with preoperative seizures achieved favorable seizure outcome following resection of temporal located glioblastoma. For the ATL group, postoperative seizure freedom was present in 13 out of 13 patients (100%). In comparison, respective rates for the GTR group were 10 out of 20 patients (50%) (p = 0.002; OR 27; 95% CI 1.4–515.9).
Conclusions
ATL in terms of a supra-total resection strategy was associated with superior favorable seizure outcome following temporal glioblastoma resection compared to GTR. Regarding above mentioned survival benefit following ATL compared to GTR, ATL as an aggressive supra-total resection regime might constitute the surgical modality of choice for temporal-located glioblastoma.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33554293</pmid><doi>10.1007/s11060-021-03705-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5905-4121</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-594X |
ispartof | Journal of neuro-oncology, 2021-04, Vol.152 (2), p.339-346 |
issn | 0167-594X 1573-7373 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7997820 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult Aged Anterior Temporal Lobectomy - methods Brain cancer Brain Neoplasms - complications Brain Neoplasms - surgery Clinical Study Convulsions & seizures Disease control Epilepsy Female Glioblastoma Glioblastoma - complications Glioblastoma - surgery Humans Male Medicine Medicine & Public Health Middle Aged Neurology Oncology Seizures Seizures - etiology Seizures - surgery Surgery Treatment Outcome |
title | Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T18%3A40%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seizure%20outcome%20in%20temporal%20glioblastoma%20surgery:%20lobectomy%20as%20a%20supratotal%20resection%20regime%20outclasses%20conventional%20gross-total%20resection&rft.jtitle=Journal%20of%20neuro-oncology&rft.au=Borger,%20Valeri&rft.date=2021-04-01&rft.volume=152&rft.issue=2&rft.spage=339&rft.epage=346&rft.pages=339-346&rft.issn=0167-594X&rft.eissn=1573-7373&rft_id=info:doi/10.1007/s11060-021-03705-x&rft_dat=%3Cproquest_pubme%3E2487427740%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2505572800&rft_id=info:pmid/33554293&rfr_iscdi=true |